论文部分内容阅读
■2004年10月28日正式当选为国家制药企业协会联合会(IFPMA)主席■2004年被《金融时报》评为“欧洲25年来最有影响办的商业领导人”■被英国FIRST杂志评为2003年度“最负责任的企业家”成功进阶三步走,魏思乐心里有“谱”诺华公司的主席兼CEO丹尼尔L·魏思乐博士从来不接受否定的回答。这位世界第五大制药商总在不懈地追求他想要的东西,而且大多数都能得到。2002年,诺华公司开始斥资40亿美元筹建位于美国麻省剑桥的一家研究机构,魏思乐决定找一位世界著名的科学家来管理它,可是他的人选哈佛医学院著名的遗传学家和心脏病专家马克·C·费什曼博士却平淡地回绝了这个邀请,称自己对现在的工作很满意。魏思
■ Officially elected as President of IFPMA on October 28, 2004 ■ Selected as “the Most Influential Business Leader in Europe in 25 Years” by the Financial Times in 2004 ■ Awarded by FIRST Magazine in UK In 2003, “the most responsible entrepreneur,” the success of the three-step walk, Wei Silen heart “spectrum.” Novartis chairman and CEO Daniel L. Weiseli Dr. never accept the negative answer. The world's fifth-largest drug maker is always relentlessly pursuing what he wants and most of them are available. In 2002, Novartis began to spend $ 4 billion to build a research institute located in Cambridge, Massachusetts. Weisile decided to find a world-famous scientist to manage it. However, he was a well-known geneticist and cardiologist at Harvard Medical School Dr. Mark C. Fishman flatly rejected the invitation and said he was satisfied with the present job. Weisi